Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista Ceres |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-737X2012000500003 |
Resumo: | Among the proposed treatments to repair lesions of degenerative joint disease (DJD), chondroprotective nutraceuticals composed by glucosamine and chondroitin sulfate are a non-invasive theraphy with properties that favors the health of the cartilage. Although used in human, it is also available for veterinary use with administration in the form of nutritional supplement independent of prescription, since they have registry only in the Inspection Service, which does not require safety and efficacy testing. The lack of such tests to prove efficacy and safety of veterinary medicines required by the Ministry of Agriculture and the lack of scientific studies proving its benefits raises doubts about the efficiency of the concentrations of such active substances. In this context, the objective of this study was to evaluate the efficacy of a veterinary chondroprotective nutraceutical based on chondroitin sulfate and glucosamine in the repair of osteochondral defects in lateral femoral condyle of 48 dogs, through clinical and radiographic analysis. The animals were divided into treatment group (TG) and control group (CG), so that only the TG received the nutraceutical every 24 hours at the rate recommended by the manufacturer. The results of the four treatment times (15, 30, 60 and 90 days) showed that the chondroprotective nutraceutical, in the rate, formulation and administration at the times used, did not improve clinical signs and radiologically did not influence in the repair process of the defects, since the treated and control groups showed similar radiographic findings at the end of the treatments. |
id |
UFV-5_c6b979aff50702fbd71a57b9309121fc |
---|---|
oai_identifier_str |
oai:scielo:S0034-737X2012000500003 |
network_acronym_str |
UFV-5 |
network_name_str |
Revista Ceres |
repository_id_str |
|
spelling |
Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysisdegenerative joint diseaseosteoarthritisarthrosischondroprotectivenutraceuticalAmong the proposed treatments to repair lesions of degenerative joint disease (DJD), chondroprotective nutraceuticals composed by glucosamine and chondroitin sulfate are a non-invasive theraphy with properties that favors the health of the cartilage. Although used in human, it is also available for veterinary use with administration in the form of nutritional supplement independent of prescription, since they have registry only in the Inspection Service, which does not require safety and efficacy testing. The lack of such tests to prove efficacy and safety of veterinary medicines required by the Ministry of Agriculture and the lack of scientific studies proving its benefits raises doubts about the efficiency of the concentrations of such active substances. In this context, the objective of this study was to evaluate the efficacy of a veterinary chondroprotective nutraceutical based on chondroitin sulfate and glucosamine in the repair of osteochondral defects in lateral femoral condyle of 48 dogs, through clinical and radiographic analysis. The animals were divided into treatment group (TG) and control group (CG), so that only the TG received the nutraceutical every 24 hours at the rate recommended by the manufacturer. The results of the four treatment times (15, 30, 60 and 90 days) showed that the chondroprotective nutraceutical, in the rate, formulation and administration at the times used, did not improve clinical signs and radiologically did not influence in the repair process of the defects, since the treated and control groups showed similar radiographic findings at the end of the treatments.Universidade Federal de Viçosa2012-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-737X2012000500003Revista Ceres v.59 n.5 2012reponame:Revista Ceresinstname:Universidade Federal de Viçosa (UFV)instacron:UFV10.1590/S0034-737X2012000500003info:eu-repo/semantics/openAccessEleotério,Renato BarrosBorges,Andréa Pacheco BatistaPontes,Kelly Cristine de SousaFernandes,Natália AlvesSoares,Priscila FerreiraSilva,Mariana BrettasMartins,Naira Jandafet SampaioMachado,João Pauloeng2015-04-07T00:00:00ZRevista |
dc.title.none.fl_str_mv |
Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis |
title |
Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis |
spellingShingle |
Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis Eleotério,Renato Barros degenerative joint disease osteoarthritis arthrosis chondroprotective nutraceutical |
title_short |
Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis |
title_full |
Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis |
title_fullStr |
Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis |
title_full_unstemmed |
Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis |
title_sort |
Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis |
author |
Eleotério,Renato Barros |
author_facet |
Eleotério,Renato Barros Borges,Andréa Pacheco Batista Pontes,Kelly Cristine de Sousa Fernandes,Natália Alves Soares,Priscila Ferreira Silva,Mariana Brettas Martins,Naira Jandafet Sampaio Machado,João Paulo |
author_role |
author |
author2 |
Borges,Andréa Pacheco Batista Pontes,Kelly Cristine de Sousa Fernandes,Natália Alves Soares,Priscila Ferreira Silva,Mariana Brettas Martins,Naira Jandafet Sampaio Machado,João Paulo |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Eleotério,Renato Barros Borges,Andréa Pacheco Batista Pontes,Kelly Cristine de Sousa Fernandes,Natália Alves Soares,Priscila Ferreira Silva,Mariana Brettas Martins,Naira Jandafet Sampaio Machado,João Paulo |
dc.subject.por.fl_str_mv |
degenerative joint disease osteoarthritis arthrosis chondroprotective nutraceutical |
topic |
degenerative joint disease osteoarthritis arthrosis chondroprotective nutraceutical |
dc.description.none.fl_txt_mv |
Among the proposed treatments to repair lesions of degenerative joint disease (DJD), chondroprotective nutraceuticals composed by glucosamine and chondroitin sulfate are a non-invasive theraphy with properties that favors the health of the cartilage. Although used in human, it is also available for veterinary use with administration in the form of nutritional supplement independent of prescription, since they have registry only in the Inspection Service, which does not require safety and efficacy testing. The lack of such tests to prove efficacy and safety of veterinary medicines required by the Ministry of Agriculture and the lack of scientific studies proving its benefits raises doubts about the efficiency of the concentrations of such active substances. In this context, the objective of this study was to evaluate the efficacy of a veterinary chondroprotective nutraceutical based on chondroitin sulfate and glucosamine in the repair of osteochondral defects in lateral femoral condyle of 48 dogs, through clinical and radiographic analysis. The animals were divided into treatment group (TG) and control group (CG), so that only the TG received the nutraceutical every 24 hours at the rate recommended by the manufacturer. The results of the four treatment times (15, 30, 60 and 90 days) showed that the chondroprotective nutraceutical, in the rate, formulation and administration at the times used, did not improve clinical signs and radiologically did not influence in the repair process of the defects, since the treated and control groups showed similar radiographic findings at the end of the treatments. |
description |
Among the proposed treatments to repair lesions of degenerative joint disease (DJD), chondroprotective nutraceuticals composed by glucosamine and chondroitin sulfate are a non-invasive theraphy with properties that favors the health of the cartilage. Although used in human, it is also available for veterinary use with administration in the form of nutritional supplement independent of prescription, since they have registry only in the Inspection Service, which does not require safety and efficacy testing. The lack of such tests to prove efficacy and safety of veterinary medicines required by the Ministry of Agriculture and the lack of scientific studies proving its benefits raises doubts about the efficiency of the concentrations of such active substances. In this context, the objective of this study was to evaluate the efficacy of a veterinary chondroprotective nutraceutical based on chondroitin sulfate and glucosamine in the repair of osteochondral defects in lateral femoral condyle of 48 dogs, through clinical and radiographic analysis. The animals were divided into treatment group (TG) and control group (CG), so that only the TG received the nutraceutical every 24 hours at the rate recommended by the manufacturer. The results of the four treatment times (15, 30, 60 and 90 days) showed that the chondroprotective nutraceutical, in the rate, formulation and administration at the times used, did not improve clinical signs and radiologically did not influence in the repair process of the defects, since the treated and control groups showed similar radiographic findings at the end of the treatments. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-737X2012000500003 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-737X2012000500003 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0034-737X2012000500003 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Universidade Federal de Viçosa |
publisher.none.fl_str_mv |
Universidade Federal de Viçosa |
dc.source.none.fl_str_mv |
Revista Ceres v.59 n.5 2012 reponame:Revista Ceres instname:Universidade Federal de Viçosa (UFV) instacron:UFV |
instname_str |
Universidade Federal de Viçosa (UFV) |
instacron_str |
UFV |
institution |
UFV |
reponame_str |
Revista Ceres |
collection |
Revista Ceres |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1728006780363997184 |